Editorial comment.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22990065)

Published in Urology on September 15, 2012

Authors

Pascal Zehnder, Urs E Studer

Articles by these authors

Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial. Eur Urol (2010) 4.18

Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol (2003) 3.58

Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol (2011) 3.47

Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44

The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol (2007) 3.20

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83

Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68

Face, content and construct validity of a novel robotic surgery simulator. J Urol (2011) 2.66

Urinary diversion. Urology (2007) 2.65

Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65

A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol (2009) 2.55

Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol (2008) 2.46

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. J Clin Oncol (2003) 2.33

Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol (2006) 2.32

Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology (2014) 2.25

Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15

Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14

Occlusion of seminal vesicles increases sexual activity in a mouse model. Eur Urol (2012) 2.03

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol (2009) 1.99

A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol (2003) 1.84

Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol (2013) 1.77

Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76

Long-term results of standard procedures in urology: the ileal neobladder. World J Urol (2006) 1.68

Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol (2007) 1.68

Is newer always better? A comparative study of 3 lithotriptor generations. J Urol (2005) 1.67

Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol (2006) 1.65

Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol (2010) 1.64

Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol (2007) 1.64

A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter. Eur Urol (2011) 1.61

Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol (2005) 1.61

Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol (2006) 1.59

Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology (2008) 1.58

Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56

Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn (2007) 1.53

Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol (2012) 1.52

Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol (2002) 1.50

Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol (2002) 1.50

Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50

The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol (2007) 1.49

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49

Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol (2012) 1.45

Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? J Urol (2009) 1.45

Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol (2011) 1.45

Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int (2014) 1.44

Percutaneous radiofrequency ablation of virtual tumours in canine kidney using Global Positioning System-like technology. BJU Int (2011) 1.43

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol (2012) 1.42

Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol (2007) 1.40

Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? J Clin Oncol (2004) 1.40

Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution? Eur Urol (2007) 1.39

Robot-assisted cystectomy: does it meet expectations? Eur Urol (2010) 1.37

Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical. Eur Urol (2011) 1.37

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol (2011) 1.24

Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol (2002) 1.16

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol (2005) 1.14

Concurrent and predictive validation of a novel robotic surgery simulator: a prospective, randomized study. J Urol (2011) 1.12

Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology (2010) 1.10

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol (2008) 1.08

Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn (2005) 1.07

Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol (2006) 1.06

Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. Prostate (2009) 1.05

Nerve-sparing open radical retropubic prostatectomy. Eur Urol (2006) 1.04

Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol (2009) 1.03

Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int (2013) 1.03

Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol (2004) 1.00

Validation of a novel robotic-assisted partial nephrectomy surgical training model. BJU Int (2012) 0.99

Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term? J Urol (2002) 0.99

Can radical prostatectomy benefit patients despite the presence of regional metastases? Eur Urol (2010) 0.97

Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes. Eur Urol (2011) 0.97

Lymph node dissection in renal cell carcinoma. Eur Urol (2011) 0.97

Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol (2002) 0.96

Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer. Oncologist (2009) 0.96

Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol (2002) 0.95

Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol (2003) 0.94

A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution? Eur Urol (2010) 0.93

Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all? J Urol (2013) 0.93

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. J Urol (2005) 0.91

Contemporary cystectomy and urinary diversion. World J Urol (2002) 0.91

The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J Urol (2006) 0.91

Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients. Eur Urol (2007) 0.90

High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy. World J Urol (2009) 0.89

Lymphadenectomy for bladder cancer: indications and controversies. Urol Clin North Am (2011) 0.89

Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol (2004) 0.89

Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? BJU Int (2007) 0.88

Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol (2004) 0.87

Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study. Eur Urol (2003) 0.87

Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955. J Urol (2004) 0.87

Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. J Urol (2007) 0.87

Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding pattern. Eur Urol (2004) 0.86

To stent or not to stent perioperatively the ureteroileal anastomosis of ileal orthotopic bladder substitutes and ileal conduits? Results of a prospective randomized trial. J Urol (2007) 0.86

The role of lymphadenectomy in high risk prostate cancer. World J Urol (2008) 0.86

An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated. Nat Clin Pract Urol (2006) 0.86